nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—Alzheimer's disease	0.493	1	CbGaD
Gliclazide—CYP2C19—Memantine—Alzheimer's disease	0.0774	0.511	CbGbCtD
Gliclazide—CYP2C9—Donepezil—Alzheimer's disease	0.0742	0.49	CbGbCtD
Gliclazide—Glyburide—ABCA1—Alzheimer's disease	0.00113	0.471	CrCbGaD
Gliclazide—Glipizide—PPARG—Alzheimer's disease	0.000828	0.345	CrCbGaD
Gliclazide—VEGFA—telencephalon—Alzheimer's disease	0.000459	0.152	CbGeAlD
Gliclazide—Chlorpropamide—PTGS1—Alzheimer's disease	0.000442	0.184	CrCbGaD
Gliclazide—ABCC8—forebrain—Alzheimer's disease	0.000329	0.109	CbGeAlD
Gliclazide—ABCC8—telencephalon—Alzheimer's disease	0.000302	0.1	CbGeAlD
Gliclazide—VEGFA—cerebellum—Alzheimer's disease	0.000255	0.0845	CbGeAlD
Gliclazide—VEGFA—brain—Alzheimer's disease	0.000207	0.0687	CbGeAlD
Gliclazide—Conjunctivitis—Memantine—Alzheimer's disease	0.000204	0.000795	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000204	0.000793	CcSEcCtD
Gliclazide—Cough—Galantamine—Alzheimer's disease	0.000204	0.000793	CcSEcCtD
Gliclazide—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000203	0.000789	CcSEcCtD
Gliclazide—Convulsion—Galantamine—Alzheimer's disease	0.000202	0.000787	CcSEcCtD
Gliclazide—Renal failure—Rivastigmine—Alzheimer's disease	0.000202	0.000786	CcSEcCtD
Gliclazide—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000201	0.000784	CcSEcCtD
Gliclazide—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000201	0.000784	CcSEcCtD
Gliclazide—Hypertension—Galantamine—Alzheimer's disease	0.000201	0.000784	CcSEcCtD
Gliclazide—Visual impairment—Donepezil—Alzheimer's disease	0.0002	0.000779	CcSEcCtD
Gliclazide—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.0002	0.000778	CcSEcCtD
Gliclazide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.0002	0.000778	CcSEcCtD
Gliclazide—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000199	0.000773	CcSEcCtD
Gliclazide—Myalgia—Galantamine—Alzheimer's disease	0.000199	0.000773	CcSEcCtD
Gliclazide—Chest pain—Galantamine—Alzheimer's disease	0.000199	0.000773	CcSEcCtD
Gliclazide—Arthralgia—Galantamine—Alzheimer's disease	0.000199	0.000773	CcSEcCtD
Gliclazide—Epistaxis—Memantine—Alzheimer's disease	0.000198	0.000771	CcSEcCtD
Gliclazide—Anxiety—Galantamine—Alzheimer's disease	0.000198	0.000771	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000197	0.000768	CcSEcCtD
Gliclazide—Sinusitis—Memantine—Alzheimer's disease	0.000197	0.000767	CcSEcCtD
Gliclazide—Sweating—Rivastigmine—Alzheimer's disease	0.000197	0.000767	CcSEcCtD
Gliclazide—Discomfort—Galantamine—Alzheimer's disease	0.000196	0.000764	CcSEcCtD
Gliclazide—Agranulocytosis—Memantine—Alzheimer's disease	0.000196	0.000763	CcSEcCtD
Gliclazide—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000194	0.000757	CcSEcCtD
Gliclazide—Dry mouth—Galantamine—Alzheimer's disease	0.000194	0.000756	CcSEcCtD
Gliclazide—Epistaxis—Rivastigmine—Alzheimer's disease	0.000194	0.000755	CcSEcCtD
Gliclazide—KCNJ11—nervous system—Alzheimer's disease	0.000194	0.0643	CbGeAlD
Gliclazide—Tinnitus—Donepezil—Alzheimer's disease	0.000194	0.000754	CcSEcCtD
Gliclazide—Sinusitis—Rivastigmine—Alzheimer's disease	0.000193	0.000751	CcSEcCtD
Gliclazide—Confusional state—Galantamine—Alzheimer's disease	0.000192	0.000747	CcSEcCtD
Gliclazide—Bradycardia—Memantine—Alzheimer's disease	0.000192	0.000747	CcSEcCtD
Gliclazide—Rhinitis—Memantine—Alzheimer's disease	0.000189	0.000736	CcSEcCtD
Gliclazide—Hepatitis—Memantine—Alzheimer's disease	0.000189	0.000734	CcSEcCtD
Gliclazide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000188	0.000731	CcSEcCtD
Gliclazide—Hypoaesthesia—Memantine—Alzheimer's disease	0.000188	0.00073	CcSEcCtD
Gliclazide—Pharyngitis—Memantine—Alzheimer's disease	0.000187	0.000729	CcSEcCtD
Gliclazide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000187	0.000727	CcSEcCtD
Gliclazide—KCNJ11—central nervous system—Alzheimer's disease	0.000187	0.0619	CbGeAlD
Gliclazide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000186	0.000726	CcSEcCtD
Gliclazide—Chills—Donepezil—Alzheimer's disease	0.000186	0.000725	CcSEcCtD
Gliclazide—Tachycardia—Galantamine—Alzheimer's disease	0.000186	0.000723	CcSEcCtD
Gliclazide—Oedema peripheral—Memantine—Alzheimer's disease	0.000186	0.000723	CcSEcCtD
Gliclazide—Arrhythmia—Donepezil—Alzheimer's disease	0.000186	0.000722	CcSEcCtD
Gliclazide—Rhinitis—Rivastigmine—Alzheimer's disease	0.000185	0.00072	CcSEcCtD
Gliclazide—Skin disorder—Galantamine—Alzheimer's disease	0.000185	0.00072	CcSEcCtD
Gliclazide—Hepatitis—Rivastigmine—Alzheimer's disease	0.000185	0.000718	CcSEcCtD
Gliclazide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000184	0.000717	CcSEcCtD
Gliclazide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000184	0.000715	CcSEcCtD
Gliclazide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000183	0.000713	CcSEcCtD
Gliclazide—KCNJ11—cerebellum—Alzheimer's disease	0.000182	0.0605	CbGeAlD
Gliclazide—Mental disorder—Donepezil—Alzheimer's disease	0.000182	0.000708	CcSEcCtD
Gliclazide—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000182	0.000708	CcSEcCtD
Gliclazide—Visual impairment—Memantine—Alzheimer's disease	0.000182	0.000707	CcSEcCtD
Gliclazide—Erythema—Donepezil—Alzheimer's disease	0.000181	0.000704	CcSEcCtD
Gliclazide—Malnutrition—Donepezil—Alzheimer's disease	0.000181	0.000704	CcSEcCtD
Gliclazide—ABCC8—nervous system—Alzheimer's disease	0.000179	0.0592	CbGeAlD
Gliclazide—Erythema multiforme—Memantine—Alzheimer's disease	0.000178	0.000694	CcSEcCtD
Gliclazide—Flatulence—Donepezil—Alzheimer's disease	0.000178	0.000694	CcSEcCtD
Gliclazide—Hypotension—Galantamine—Alzheimer's disease	0.000178	0.000693	CcSEcCtD
Gliclazide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000178	0.000692	CcSEcCtD
Gliclazide—Tension—Donepezil—Alzheimer's disease	0.000177	0.000691	CcSEcCtD
Gliclazide—Eye disorder—Memantine—Alzheimer's disease	0.000176	0.000686	CcSEcCtD
Gliclazide—Tinnitus—Memantine—Alzheimer's disease	0.000176	0.000684	CcSEcCtD
Gliclazide—Nervousness—Donepezil—Alzheimer's disease	0.000176	0.000684	CcSEcCtD
Gliclazide—Flushing—Memantine—Alzheimer's disease	0.000175	0.000681	CcSEcCtD
Gliclazide—Back pain—Donepezil—Alzheimer's disease	0.000175	0.000681	CcSEcCtD
Gliclazide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000174	0.000679	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000174	0.000675	CcSEcCtD
Gliclazide—Eye disorder—Rivastigmine—Alzheimer's disease	0.000172	0.000671	CcSEcCtD
Gliclazide—Insomnia—Galantamine—Alzheimer's disease	0.000172	0.00067	CcSEcCtD
Gliclazide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000172	0.00067	CcSEcCtD
Gliclazide—ABCC8—central nervous system—Alzheimer's disease	0.000172	0.057	CbGeAlD
Gliclazide—Flushing—Rivastigmine—Alzheimer's disease	0.000171	0.000667	CcSEcCtD
Gliclazide—Paraesthesia—Galantamine—Alzheimer's disease	0.000171	0.000666	CcSEcCtD
Gliclazide—Tremor—Donepezil—Alzheimer's disease	0.000169	0.000659	CcSEcCtD
Gliclazide—Somnolence—Galantamine—Alzheimer's disease	0.000169	0.000659	CcSEcCtD
Gliclazide—Chills—Memantine—Alzheimer's disease	0.000169	0.000659	CcSEcCtD
Gliclazide—Arrhythmia—Memantine—Alzheimer's disease	0.000169	0.000656	CcSEcCtD
Gliclazide—ABCC8—cerebellum—Alzheimer's disease	0.000168	0.0557	CbGeAlD
Gliclazide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000168	0.000653	CcSEcCtD
Gliclazide—Dyspepsia—Galantamine—Alzheimer's disease	0.000168	0.000652	CcSEcCtD
Gliclazide—Anaemia—Donepezil—Alzheimer's disease	0.000167	0.000651	CcSEcCtD
Gliclazide—Agitation—Donepezil—Alzheimer's disease	0.000166	0.000647	CcSEcCtD
Gliclazide—Chills—Rivastigmine—Alzheimer's disease	0.000166	0.000644	CcSEcCtD
Gliclazide—Mental disorder—Memantine—Alzheimer's disease	0.000165	0.000643	CcSEcCtD
Gliclazide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000165	0.000642	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000164	0.00064	CcSEcCtD
Gliclazide—Malnutrition—Memantine—Alzheimer's disease	0.000164	0.000639	CcSEcCtD
Gliclazide—Fatigue—Galantamine—Alzheimer's disease	0.000164	0.000639	CcSEcCtD
Gliclazide—Malaise—Donepezil—Alzheimer's disease	0.000163	0.000635	CcSEcCtD
Gliclazide—Constipation—Galantamine—Alzheimer's disease	0.000163	0.000634	CcSEcCtD
Gliclazide—Flatulence—Memantine—Alzheimer's disease	0.000162	0.00063	CcSEcCtD
Gliclazide—Mental disorder—Rivastigmine—Alzheimer's disease	0.000162	0.000629	CcSEcCtD
Gliclazide—Tension—Memantine—Alzheimer's disease	0.000161	0.000627	CcSEcCtD
Gliclazide—Malnutrition—Rivastigmine—Alzheimer's disease	0.000161	0.000625	CcSEcCtD
Gliclazide—Erythema—Rivastigmine—Alzheimer's disease	0.000161	0.000625	CcSEcCtD
Gliclazide—Nervousness—Memantine—Alzheimer's disease	0.000159	0.000621	CcSEcCtD
Gliclazide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000159	0.000619	CcSEcCtD
Gliclazide—Back pain—Memantine—Alzheimer's disease	0.000159	0.000618	CcSEcCtD
Gliclazide—Flatulence—Rivastigmine—Alzheimer's disease	0.000158	0.000616	CcSEcCtD
Gliclazide—Cough—Donepezil—Alzheimer's disease	0.000158	0.000614	CcSEcCtD
Gliclazide—Tension—Rivastigmine—Alzheimer's disease	0.000158	0.000614	CcSEcCtD
Gliclazide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000157	0.000611	CcSEcCtD
Gliclazide—Convulsion—Donepezil—Alzheimer's disease	0.000157	0.00061	CcSEcCtD
Gliclazide—Hypertension—Donepezil—Alzheimer's disease	0.000156	0.000608	CcSEcCtD
Gliclazide—Nervousness—Rivastigmine—Alzheimer's disease	0.000156	0.000607	CcSEcCtD
Gliclazide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000156	0.000606	CcSEcCtD
Gliclazide—Back pain—Rivastigmine—Alzheimer's disease	0.000155	0.000605	CcSEcCtD
Gliclazide—Myalgia—Donepezil—Alzheimer's disease	0.000154	0.000599	CcSEcCtD
Gliclazide—Arthralgia—Donepezil—Alzheimer's disease	0.000154	0.000599	CcSEcCtD
Gliclazide—Chest pain—Donepezil—Alzheimer's disease	0.000154	0.000599	CcSEcCtD
Gliclazide—Tremor—Memantine—Alzheimer's disease	0.000154	0.000599	CcSEcCtD
Gliclazide—Anxiety—Donepezil—Alzheimer's disease	0.000153	0.000597	CcSEcCtD
Gliclazide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000152	0.000593	CcSEcCtD
Gliclazide—Discomfort—Donepezil—Alzheimer's disease	0.000152	0.000592	CcSEcCtD
Gliclazide—Anaemia—Memantine—Alzheimer's disease	0.000152	0.000591	CcSEcCtD
Gliclazide—Agitation—Memantine—Alzheimer's disease	0.000151	0.000587	CcSEcCtD
Gliclazide—Dry mouth—Donepezil—Alzheimer's disease	0.000151	0.000586	CcSEcCtD
Gliclazide—Abdominal pain—Galantamine—Alzheimer's disease	0.000151	0.000586	CcSEcCtD
Gliclazide—Body temperature increased—Galantamine—Alzheimer's disease	0.000151	0.000586	CcSEcCtD
Gliclazide—Tremor—Rivastigmine—Alzheimer's disease	0.000151	0.000586	CcSEcCtD
Gliclazide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000149	0.00058	CcSEcCtD
Gliclazide—Confusional state—Donepezil—Alzheimer's disease	0.000149	0.000579	CcSEcCtD
Gliclazide—Anaemia—Rivastigmine—Alzheimer's disease	0.000148	0.000578	CcSEcCtD
Gliclazide—KCNJ11—brain—Alzheimer's disease	0.000148	0.0491	CbGeAlD
Gliclazide—Malaise—Memantine—Alzheimer's disease	0.000148	0.000576	CcSEcCtD
Gliclazide—Agitation—Rivastigmine—Alzheimer's disease	0.000148	0.000575	CcSEcCtD
Gliclazide—Leukopenia—Memantine—Alzheimer's disease	0.000147	0.000572	CcSEcCtD
Gliclazide—Infection—Donepezil—Alzheimer's disease	0.000147	0.000571	CcSEcCtD
Gliclazide—Palpitations—Memantine—Alzheimer's disease	0.000145	0.000565	CcSEcCtD
Gliclazide—Malaise—Rivastigmine—Alzheimer's disease	0.000145	0.000564	CcSEcCtD
Gliclazide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000145	0.000563	CcSEcCtD
Gliclazide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000145	0.000562	CcSEcCtD
Gliclazide—Loss of consciousness—Memantine—Alzheimer's disease	0.000144	0.000562	CcSEcCtD
Gliclazide—Cough—Memantine—Alzheimer's disease	0.000143	0.000558	CcSEcCtD
Gliclazide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000143	0.000555	CcSEcCtD
Gliclazide—Convulsion—Memantine—Alzheimer's disease	0.000142	0.000554	CcSEcCtD
Gliclazide—Palpitations—Rivastigmine—Alzheimer's disease	0.000142	0.000552	CcSEcCtD
Gliclazide—Hypertension—Memantine—Alzheimer's disease	0.000142	0.000552	CcSEcCtD
Gliclazide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000141	0.00055	CcSEcCtD
Gliclazide—Hypersensitivity—Galantamine—Alzheimer's disease	0.00014	0.000546	CcSEcCtD
Gliclazide—Cough—Rivastigmine—Alzheimer's disease	0.00014	0.000546	CcSEcCtD
Gliclazide—Myalgia—Memantine—Alzheimer's disease	0.00014	0.000544	CcSEcCtD
Gliclazide—Arthralgia—Memantine—Alzheimer's disease	0.00014	0.000544	CcSEcCtD
Gliclazide—Chest pain—Memantine—Alzheimer's disease	0.00014	0.000544	CcSEcCtD
Gliclazide—Anxiety—Memantine—Alzheimer's disease	0.000139	0.000542	CcSEcCtD
Gliclazide—Convulsion—Rivastigmine—Alzheimer's disease	0.000139	0.000542	CcSEcCtD
Gliclazide—Hypertension—Rivastigmine—Alzheimer's disease	0.000139	0.00054	CcSEcCtD
Gliclazide—Discomfort—Memantine—Alzheimer's disease	0.000138	0.000538	CcSEcCtD
Gliclazide—Hypotension—Donepezil—Alzheimer's disease	0.000138	0.000537	CcSEcCtD
Gliclazide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000137	0.000532	CcSEcCtD
Gliclazide—Chest pain—Rivastigmine—Alzheimer's disease	0.000137	0.000532	CcSEcCtD
Gliclazide—Myalgia—Rivastigmine—Alzheimer's disease	0.000137	0.000532	CcSEcCtD
Gliclazide—Dry mouth—Memantine—Alzheimer's disease	0.000137	0.000532	CcSEcCtD
Gliclazide—Asthenia—Galantamine—Alzheimer's disease	0.000137	0.000532	CcSEcCtD
Gliclazide—ABCC8—brain—Alzheimer's disease	0.000136	0.0452	CbGeAlD
Gliclazide—Anxiety—Rivastigmine—Alzheimer's disease	0.000136	0.00053	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000136	0.000529	CcSEcCtD
Gliclazide—Confusional state—Memantine—Alzheimer's disease	0.000135	0.000526	CcSEcCtD
Gliclazide—Discomfort—Rivastigmine—Alzheimer's disease	0.000135	0.000526	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000134	0.000523	CcSEcCtD
Gliclazide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000134	0.000521	CcSEcCtD
Gliclazide—Insomnia—Donepezil—Alzheimer's disease	0.000133	0.00052	CcSEcCtD
Gliclazide—Infection—Memantine—Alzheimer's disease	0.000133	0.000518	CcSEcCtD
Gliclazide—Paraesthesia—Donepezil—Alzheimer's disease	0.000133	0.000516	CcSEcCtD
Gliclazide—Confusional state—Rivastigmine—Alzheimer's disease	0.000132	0.000514	CcSEcCtD
Gliclazide—Dyspnoea—Donepezil—Alzheimer's disease	0.000132	0.000512	CcSEcCtD
Gliclazide—Nervous system disorder—Memantine—Alzheimer's disease	0.000131	0.000511	CcSEcCtD
Gliclazide—Somnolence—Donepezil—Alzheimer's disease	0.000131	0.000511	CcSEcCtD
Gliclazide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000131	0.000511	CcSEcCtD
Gliclazide—Tachycardia—Memantine—Alzheimer's disease	0.000131	0.000509	CcSEcCtD
Gliclazide—Diarrhoea—Galantamine—Alzheimer's disease	0.00013	0.000507	CcSEcCtD
Gliclazide—Infection—Rivastigmine—Alzheimer's disease	0.00013	0.000507	CcSEcCtD
Gliclazide—Skin disorder—Memantine—Alzheimer's disease	0.00013	0.000507	CcSEcCtD
Gliclazide—Dyspepsia—Donepezil—Alzheimer's disease	0.00013	0.000506	CcSEcCtD
Gliclazide—Hyperhidrosis—Memantine—Alzheimer's disease	0.00013	0.000504	CcSEcCtD
Gliclazide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000129	0.0005	CcSEcCtD
Gliclazide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000128	0.0005	CcSEcCtD
Gliclazide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000128	0.000498	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000127	0.000496	CcSEcCtD
Gliclazide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000127	0.000496	CcSEcCtD
Gliclazide—Fatigue—Donepezil—Alzheimer's disease	0.000127	0.000495	CcSEcCtD
Gliclazide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000127	0.000493	CcSEcCtD
Gliclazide—Constipation—Donepezil—Alzheimer's disease	0.000126	0.000491	CcSEcCtD
Gliclazide—Pain—Donepezil—Alzheimer's disease	0.000126	0.000491	CcSEcCtD
Gliclazide—Dizziness—Galantamine—Alzheimer's disease	0.000126	0.00049	CcSEcCtD
Gliclazide—Hypotension—Memantine—Alzheimer's disease	0.000125	0.000487	CcSEcCtD
Gliclazide—Hypotension—Rivastigmine—Alzheimer's disease	0.000123	0.000477	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000122	0.000475	CcSEcCtD
Gliclazide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000122	0.000473	CcSEcCtD
Gliclazide—Insomnia—Memantine—Alzheimer's disease	0.000121	0.000472	CcSEcCtD
Gliclazide—Vomiting—Galantamine—Alzheimer's disease	0.000121	0.000471	CcSEcCtD
Gliclazide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000121	0.00047	CcSEcCtD
Gliclazide—Paraesthesia—Memantine—Alzheimer's disease	0.00012	0.000468	CcSEcCtD
Gliclazide—Rash—Galantamine—Alzheimer's disease	0.00012	0.000467	CcSEcCtD
Gliclazide—Dermatitis—Galantamine—Alzheimer's disease	0.00012	0.000467	CcSEcCtD
Gliclazide—Dyspnoea—Memantine—Alzheimer's disease	0.000119	0.000465	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000119	0.000465	CcSEcCtD
Gliclazide—Headache—Galantamine—Alzheimer's disease	0.000119	0.000464	CcSEcCtD
Gliclazide—Somnolence—Memantine—Alzheimer's disease	0.000119	0.000464	CcSEcCtD
Gliclazide—Insomnia—Rivastigmine—Alzheimer's disease	0.000119	0.000461	CcSEcCtD
Gliclazide—Dyspepsia—Memantine—Alzheimer's disease	0.000118	0.000459	CcSEcCtD
Gliclazide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000118	0.000458	CcSEcCtD
Gliclazide—Urticaria—Donepezil—Alzheimer's disease	0.000117	0.000456	CcSEcCtD
Gliclazide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000117	0.000455	CcSEcCtD
Gliclazide—Abdominal pain—Donepezil—Alzheimer's disease	0.000117	0.000454	CcSEcCtD
Gliclazide—Body temperature increased—Donepezil—Alzheimer's disease	0.000117	0.000454	CcSEcCtD
Gliclazide—Somnolence—Rivastigmine—Alzheimer's disease	0.000117	0.000454	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000116	0.00045	CcSEcCtD
Gliclazide—Fatigue—Memantine—Alzheimer's disease	0.000116	0.00045	CcSEcCtD
Gliclazide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000115	0.000449	CcSEcCtD
Gliclazide—Constipation—Memantine—Alzheimer's disease	0.000115	0.000446	CcSEcCtD
Gliclazide—Pain—Memantine—Alzheimer's disease	0.000115	0.000446	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000113	0.000441	CcSEcCtD
Gliclazide—Nausea—Galantamine—Alzheimer's disease	0.000113	0.00044	CcSEcCtD
Gliclazide—Fatigue—Rivastigmine—Alzheimer's disease	0.000113	0.00044	CcSEcCtD
Gliclazide—Pain—Rivastigmine—Alzheimer's disease	0.000112	0.000436	CcSEcCtD
Gliclazide—Constipation—Rivastigmine—Alzheimer's disease	0.000112	0.000436	CcSEcCtD
Gliclazide—Feeling abnormal—Memantine—Alzheimer's disease	0.00011	0.00043	CcSEcCtD
Gliclazide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00011	0.000427	CcSEcCtD
Gliclazide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000109	0.000423	CcSEcCtD
Gliclazide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000108	0.00042	CcSEcCtD
Gliclazide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000107	0.000417	CcSEcCtD
Gliclazide—Urticaria—Memantine—Alzheimer's disease	0.000106	0.000414	CcSEcCtD
Gliclazide—Body temperature increased—Memantine—Alzheimer's disease	0.000106	0.000412	CcSEcCtD
Gliclazide—Abdominal pain—Memantine—Alzheimer's disease	0.000106	0.000412	CcSEcCtD
Gliclazide—Asthenia—Donepezil—Alzheimer's disease	0.000106	0.000412	CcSEcCtD
Gliclazide—Pruritus—Donepezil—Alzheimer's disease	0.000104	0.000406	CcSEcCtD
Gliclazide—Urticaria—Rivastigmine—Alzheimer's disease	0.000104	0.000405	CcSEcCtD
Gliclazide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000104	0.000403	CcSEcCtD
Gliclazide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000104	0.000403	CcSEcCtD
Gliclazide—Diarrhoea—Donepezil—Alzheimer's disease	0.000101	0.000393	CcSEcCtD
Gliclazide—Hypersensitivity—Memantine—Alzheimer's disease	9.87e-05	0.000384	CcSEcCtD
Gliclazide—ALB—brain—Alzheimer's disease	9.77e-05	0.0324	CbGeAlD
Gliclazide—Dizziness—Donepezil—Alzheimer's disease	9.76e-05	0.00038	CcSEcCtD
Gliclazide—Hypersensitivity—Rivastigmine—Alzheimer's disease	9.66e-05	0.000376	CcSEcCtD
Gliclazide—Asthenia—Memantine—Alzheimer's disease	9.62e-05	0.000374	CcSEcCtD
Gliclazide—Pruritus—Memantine—Alzheimer's disease	9.48e-05	0.000369	CcSEcCtD
Gliclazide—Asthenia—Rivastigmine—Alzheimer's disease	9.41e-05	0.000366	CcSEcCtD
Gliclazide—Vomiting—Donepezil—Alzheimer's disease	9.38e-05	0.000365	CcSEcCtD
Gliclazide—Rash—Donepezil—Alzheimer's disease	9.31e-05	0.000362	CcSEcCtD
Gliclazide—Dermatitis—Donepezil—Alzheimer's disease	9.3e-05	0.000362	CcSEcCtD
Gliclazide—Pruritus—Rivastigmine—Alzheimer's disease	9.28e-05	0.000361	CcSEcCtD
Gliclazide—Headache—Donepezil—Alzheimer's disease	9.25e-05	0.00036	CcSEcCtD
Gliclazide—Diarrhoea—Memantine—Alzheimer's disease	9.17e-05	0.000357	CcSEcCtD
Gliclazide—Diarrhoea—Rivastigmine—Alzheimer's disease	8.97e-05	0.000349	CcSEcCtD
Gliclazide—Dizziness—Memantine—Alzheimer's disease	8.86e-05	0.000345	CcSEcCtD
Gliclazide—Nausea—Donepezil—Alzheimer's disease	8.77e-05	0.000341	CcSEcCtD
Gliclazide—Dizziness—Rivastigmine—Alzheimer's disease	8.67e-05	0.000337	CcSEcCtD
Gliclazide—Vomiting—Memantine—Alzheimer's disease	8.52e-05	0.000332	CcSEcCtD
Gliclazide—Rash—Memantine—Alzheimer's disease	8.45e-05	0.000329	CcSEcCtD
Gliclazide—Dermatitis—Memantine—Alzheimer's disease	8.44e-05	0.000329	CcSEcCtD
Gliclazide—Headache—Memantine—Alzheimer's disease	8.4e-05	0.000327	CcSEcCtD
Gliclazide—Vomiting—Rivastigmine—Alzheimer's disease	8.34e-05	0.000324	CcSEcCtD
Gliclazide—Rash—Rivastigmine—Alzheimer's disease	8.27e-05	0.000322	CcSEcCtD
Gliclazide—Dermatitis—Rivastigmine—Alzheimer's disease	8.26e-05	0.000321	CcSEcCtD
Gliclazide—Headache—Rivastigmine—Alzheimer's disease	8.21e-05	0.00032	CcSEcCtD
Gliclazide—Nausea—Memantine—Alzheimer's disease	7.96e-05	0.00031	CcSEcCtD
Gliclazide—Nausea—Rivastigmine—Alzheimer's disease	7.79e-05	0.000303	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—TP53—Alzheimer's disease	3.03e-05	0.000325	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—Alzheimer's disease	3e-05	0.000323	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CA4—Alzheimer's disease	2.97e-05	0.00032	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PSEN2—Alzheimer's disease	2.97e-05	0.000319	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—BCHE—Alzheimer's disease	2.95e-05	0.000317	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.93e-05	0.000315	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.9e-05	0.000312	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PLCB1—Alzheimer's disease	2.87e-05	0.000309	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.86e-05	0.000308	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	2.83e-05	0.000305	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—Alzheimer's disease	2.83e-05	0.000304	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GAPDHS—Alzheimer's disease	2.79e-05	0.0003	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PLCB1—Alzheimer's disease	2.78e-05	0.000299	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ABCA1—Alzheimer's disease	2.78e-05	0.000299	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—Alzheimer's disease	2.77e-05	0.000298	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.76e-05	0.000297	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	2.75e-05	0.000296	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—INPP5D—Alzheimer's disease	2.74e-05	0.000295	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NPY—Alzheimer's disease	2.73e-05	0.000294	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—Alzheimer's disease	2.73e-05	0.000293	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IAPP—Alzheimer's disease	2.71e-05	0.000292	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TF—Alzheimer's disease	2.71e-05	0.000292	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCA1—Alzheimer's disease	2.7e-05	0.00029	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CA4—Alzheimer's disease	2.67e-05	0.000287	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.67e-05	0.000287	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	2.66e-05	0.000286	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ATP5A1—Alzheimer's disease	2.65e-05	0.000285	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CRH—Alzheimer's disease	2.64e-05	0.000283	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.61e-05	0.00028	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—Alzheimer's disease	2.59e-05	0.000278	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLD3—Alzheimer's disease	2.53e-05	0.000272	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.53e-05	0.000272	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	2.51e-05	0.00027	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NPS—Alzheimer's disease	2.5e-05	0.000269	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.5e-05	0.000269	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PPP3CA—Alzheimer's disease	2.49e-05	0.000267	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GAB2—Alzheimer's disease	2.48e-05	0.000267	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTK2B—Alzheimer's disease	2.45e-05	0.000263	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.43e-05	0.000262	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HSD17B10—Alzheimer's disease	2.42e-05	0.000261	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—APP—Alzheimer's disease	2.42e-05	0.00026	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARGC1A—Alzheimer's disease	2.4e-05	0.000258	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—HMOX1—Alzheimer's disease	2.39e-05	0.000257	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GAB2—Alzheimer's disease	2.38e-05	0.000256	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SST—Alzheimer's disease	2.38e-05	0.000256	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK2—Alzheimer's disease	2.38e-05	0.000256	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	2.38e-05	0.000256	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.38e-05	0.000256	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.37e-05	0.000255	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GSK3A—Alzheimer's disease	2.36e-05	0.000254	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.35e-05	0.000253	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP46A1—Alzheimer's disease	2.33e-05	0.000251	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	2.33e-05	0.000251	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARGC1A—Alzheimer's disease	2.32e-05	0.00025	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APP—Alzheimer's disease	2.32e-05	0.00025	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—HMOX1—Alzheimer's disease	2.31e-05	0.000249	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.29e-05	0.000246	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLD3—Alzheimer's disease	2.27e-05	0.000244	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.27e-05	0.000244	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ND1—Alzheimer's disease	2.25e-05	0.000242	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.24e-05	0.000241	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.2e-05	0.000237	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	2.2e-05	0.000237	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—Alzheimer's disease	2.2e-05	0.000236	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PLCB1—Alzheimer's disease	2.19e-05	0.000236	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—LPL—Alzheimer's disease	2.18e-05	0.000235	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	2.17e-05	0.000234	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.17e-05	0.000233	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.13e-05	0.000229	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—LPL—Alzheimer's disease	2.12e-05	0.000228	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	2.09e-05	0.000225	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—Alzheimer's disease	2.08e-05	0.000224	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.07e-05	0.000222	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.07e-05	0.000222	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NGFR—Alzheimer's disease	2.05e-05	0.00022	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.04e-05	0.00022	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—Alzheimer's disease	2.04e-05	0.00022	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ND1—Alzheimer's disease	2.02e-05	0.000217	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.01e-05	0.000216	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADAM10—Alzheimer's disease	2e-05	0.000215	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.98e-05	0.000213	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.98e-05	0.000212	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SOD1—Alzheimer's disease	1.97e-05	0.000212	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—Alzheimer's disease	1.96e-05	0.000211	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—Alzheimer's disease	1.94e-05	0.000209	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.94e-05	0.000208	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.91e-05	0.000205	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—Alzheimer's disease	1.91e-05	0.000205	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—S100B—Alzheimer's disease	1.89e-05	0.000203	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF2—Alzheimer's disease	1.87e-05	0.000201	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.84e-05	0.000198	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CALM1—Alzheimer's disease	1.84e-05	0.000197	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOE—Alzheimer's disease	1.83e-05	0.000197	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAV1—Alzheimer's disease	1.81e-05	0.000195	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.81e-05	0.000194	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.8e-05	0.000194	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF2—Alzheimer's disease	1.8e-05	0.000193	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CALM1—Alzheimer's disease	1.78e-05	0.000191	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOE—Alzheimer's disease	1.77e-05	0.000191	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CAV1—Alzheimer's disease	1.76e-05	0.000189	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1R—Alzheimer's disease	1.74e-05	0.000187	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.74e-05	0.000187	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PRKCG—Alzheimer's disease	1.69e-05	0.000181	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—Alzheimer's disease	1.68e-05	0.000181	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LPL—Alzheimer's disease	1.67e-05	0.000179	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MEF2C—Alzheimer's disease	1.65e-05	0.000178	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.65e-05	0.000177	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.64e-05	0.000177	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PRKCG—Alzheimer's disease	1.62e-05	0.000174	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARG—Alzheimer's disease	1.59e-05	0.000171	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.58e-05	0.00017	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NGF—Alzheimer's disease	1.58e-05	0.00017	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—Alzheimer's disease	1.57e-05	0.000169	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—INS—Alzheimer's disease	1.56e-05	0.000168	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.56e-05	0.000168	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARG—Alzheimer's disease	1.54e-05	0.000166	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR5—Alzheimer's disease	1.54e-05	0.000165	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	1.52e-05	0.000164	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—INS—Alzheimer's disease	1.52e-05	0.000163	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2A—Alzheimer's disease	1.5e-05	0.000162	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLAU—Alzheimer's disease	1.48e-05	0.000159	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CALM1—Alzheimer's disease	1.46e-05	0.000157	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TPI1—Alzheimer's disease	1.45e-05	0.000156	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CHAT—Alzheimer's disease	1.45e-05	0.000156	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—AKT1—Alzheimer's disease	1.45e-05	0.000156	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CAV1—Alzheimer's disease	1.44e-05	0.000155	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.42e-05	0.000153	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—AKT1—Alzheimer's disease	1.42e-05	0.000153	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.42e-05	0.000153	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CALM1—Alzheimer's disease	1.4e-05	0.000151	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	1.4e-05	0.00015	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOE—Alzheimer's disease	1.4e-05	0.00015	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—Alzheimer's disease	1.4e-05	0.00015	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MAOB—Alzheimer's disease	1.39e-05	0.00015	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CAV1—Alzheimer's disease	1.38e-05	0.000149	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—F2—Alzheimer's disease	1.37e-05	0.000148	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—Alzheimer's disease	1.37e-05	0.000147	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS2—Alzheimer's disease	1.36e-05	0.000146	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GAPDH—Alzheimer's disease	1.34e-05	0.000144	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ESR1—Alzheimer's disease	1.33e-05	0.000143	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—Alzheimer's disease	1.33e-05	0.000143	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.32e-05	0.000142	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—F2—Alzheimer's disease	1.32e-05	0.000142	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.31e-05	0.000141	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.3e-05	0.00014	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.3e-05	0.00014	CbGpPWpGaD
Gliclazide—ALB—Metabolism—A2M—Alzheimer's disease	1.29e-05	0.000139	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.29e-05	0.000139	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOTCH1—Alzheimer's disease	1.29e-05	0.000139	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—Alzheimer's disease	1.25e-05	0.000135	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.25e-05	0.000134	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—Alzheimer's disease	1.22e-05	0.000131	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GSK3B—Alzheimer's disease	1.21e-05	0.00013	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.2e-05	0.000129	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—Alzheimer's disease	1.2e-05	0.000129	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CREB1—Alzheimer's disease	1.2e-05	0.000129	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—Alzheimer's disease	1.19e-05	0.000128	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.19e-05	0.000128	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.19e-05	0.000128	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.19e-05	0.000128	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.18e-05	0.000127	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—Alzheimer's disease	1.17e-05	0.000126	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.16e-05	0.000125	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—Alzheimer's disease	1.15e-05	0.000124	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.15e-05	0.000124	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.14e-05	0.000122	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ACHE—Alzheimer's disease	1.13e-05	0.000121	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INPP5D—Alzheimer's disease	1.11e-05	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.1e-05	0.000118	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—Alzheimer's disease	1.09e-05	0.000117	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.08e-05	0.000117	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.07e-05	0.000115	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.06e-05	0.000114	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ENO1—Alzheimer's disease	1.05e-05	0.000113	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS1—Alzheimer's disease	1.05e-05	0.000113	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—Alzheimer's disease	1.05e-05	0.000113	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.04e-05	0.000111	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2D6—Alzheimer's disease	1.03e-05	0.000111	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.01e-05	0.000109	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	9.99e-06	0.000107	CbGpPWpGaD
Gliclazide—ALB—Metabolism—BCHE—Alzheimer's disease	9.8e-06	0.000105	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	9.72e-06	0.000105	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ENO1—Alzheimer's disease	9.47e-06	0.000102	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	9.47e-06	0.000102	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.44e-06	0.000102	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	9.28e-06	9.98e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLCB1—Alzheimer's disease	9.25e-06	9.95e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	9.21e-06	9.91e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	9.11e-06	9.79e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.07e-06	9.76e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCA1—Alzheimer's disease	8.97e-06	9.64e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CASP3—Alzheimer's disease	8.89e-06	9.56e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—BCHE—Alzheimer's disease	8.8e-06	9.46e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	8.63e-06	9.28e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	8.63e-06	9.28e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.46e-06	9.1e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	8.3e-06	8.93e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MAPK8—Alzheimer's disease	8.17e-06	8.78e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.15e-06	8.76e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	8.05e-06	8.66e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	8.02e-06	8.63e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—Alzheimer's disease	7.85e-06	8.44e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARGC1A—Alzheimer's disease	7.73e-06	8.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMOX1—Alzheimer's disease	7.69e-06	8.27e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	7.57e-06	8.14e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.43e-06	7.99e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.34e-06	7.89e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—Alzheimer's disease	7.21e-06	7.75e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPL—Alzheimer's disease	7.04e-06	7.57e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.94e-06	7.46e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—Alzheimer's disease	6.92e-06	7.44e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.91e-06	7.43e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—Alzheimer's disease	6.34e-06	6.81e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.33e-06	6.8e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPL—Alzheimer's disease	6.32e-06	6.79e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKT1—Alzheimer's disease	6.3e-06	6.77e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.3e-06	6.77e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKT1—Alzheimer's disease	6.11e-06	6.57e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—Alzheimer's disease	5.93e-06	6.38e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CALM1—Alzheimer's disease	5.92e-06	6.36e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOE—Alzheimer's disease	5.9e-06	6.34e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAV1—Alzheimer's disease	5.84e-06	6.28e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.76e-06	6.19e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—Alzheimer's disease	5.7e-06	6.13e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.69e-06	6.12e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CALM1—Alzheimer's disease	5.31e-06	5.71e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOE—Alzheimer's disease	5.29e-06	5.69e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAV1—Alzheimer's disease	5.25e-06	5.64e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—Alzheimer's disease	5.22e-06	5.61e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.19e-06	5.58e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—Alzheimer's disease	5.14e-06	5.52e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—Alzheimer's disease	5.04e-06	5.42e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT1—Alzheimer's disease	5.01e-06	5.39e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.84e-06	5.21e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.83e-06	5.19e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT1—Alzheimer's disease	4.81e-06	5.17e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.78e-06	5.14e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.61e-06	4.96e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—Alzheimer's disease	4.52e-06	4.86e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—Alzheimer's disease	4.42e-06	4.75e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.2e-06	4.52e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—Alzheimer's disease	4.12e-06	4.43e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—Alzheimer's disease	4.04e-06	4.35e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.97e-06	4.27e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.63e-06	3.9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.62e-06	3.89e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.31e-06	3.56e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKT1—Alzheimer's disease	2.03e-06	2.18e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.82e-06	1.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.66e-06	1.79e-05	CbGpPWpGaD
